[Hepatitis C in the HIV-infected person].
Teruya
Katsuji
K
AIDS Clinical Center, International Medical Center of Japan.
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D018450:Disease Progression; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D006526:Hepatitis C / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D016031:Liver Transplantation; D011379:Prognosis; D012254:Ribavirin / Q000627:therapeutic use; D013695:Temperance
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons